User profiles for Jonathan E Millar

Jonathan Millar

BG Pandemic Science Hub, CIR, University of Edinburgh
Verified email at ed.ac.uk
Cited by 6435

[HTML][HTML] Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

CD Russell, JE Millar, JK Baillie - The lancet, 2020 - thelancet.com
The 2019 novel coronavirus (2019-nCoV) outbreak is a major challenge for clinicians. The
clinical course of patients remains to be fully characterised, little data are available that …

[HTML][HTML] The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology

JE Millar, JP Fanning, CI McDonald, DF McAuley… - Critical care, 2016 - Springer
Extracorporeal membrane oxygenation (ECMO) is a technology capable of providing short-term
mechanical support to the heart, lungs or both. Over the last decade, the number of …

Effect of lower tidal volume ventilation facilitated by extracorporeal carbon dioxide removal vs standard care ventilation on 90-day mortality in patients with acute …

…, A Bentley, DA Harrison, D Brodie, AJ Boyle, JE Millar… - Jama, 2021 - jamanetwork.com
Importance In patients who require mechanical ventilation for acute hypoxemic respiratory
failure, further reduction in tidal volumes, compared with conventional low tidal volume …

SARS-CoV-2 environmental contamination from hospitalised patients with COVID-19 receiving aerosol-generating procedures

…, J Zhou, EF Windle, I Nur, R Lall, C Ji, JE Millar… - Thorax, 2022 - thorax.bmj.com
… In contrast, only 4/90 (4%) and 6/90 (7%) of all air and surface samples tested positive (positive
for E and ORF1a) for viral RNA respectively, although there were an additional 10 …

[HTML][HTML] Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit

…, JP Fanning, M Bouquet, JE Millar… - Intensive care medicine …, 2019 - Springer
Background Extracorporeal membrane oxygenation (ECMO) is a life-saving modality used
to manage cardiopulmonary failure refractory to conventional medical and surgical therapies. …

[HTML][HTML] Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19

…, B Wang, M Zechner, MC Swets, JE Millar… - Scientific reports, 2020 - nature.com
The increasing body of literature describing the role of host factors in COVID-19 pathogenesis
demonstrates the need to combine diverse, multi-omic data to evaluate and substantiate …

[HTML][HTML] An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients

…, B Liquet, S Hinton, A Vuorinen, G Booth, JE Millar… - Critical Care, 2021 - Springer
Background Heterogeneous respiratory system static compliance (C RS ) values and levels
of hypoxemia in patients with novel coronavirus disease (COVID-19) requiring mechanical …

[HTML][HTML] Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study

JE Millar, L Neyton, S Seth, J Dunning, L Merson… - Scientific Reports, 2022 - nature.com
COVID-19 is clinically characterised by fever, cough, and dyspnoea. Symptoms affecting
other organ systems have been reported. However, it is the clinical associations of different …

Administration of mesenchymal stem cells during ECMO results in a rapid decline in oxygenator performance

JE Millar, V Von Bahr, MV Malfertheiner, KK Ki… - Thorax, 2019 - thorax.bmj.com
Mesenchymal stem cells (MSCs) have attracted attention as a potential therapy for Acute
Respiratory Distress Syndrome (ARDS). At the same time, the use of extracorporeal membrane …

[HTML][HTML] Current understanding of leukocyte phenotypic and functional modulation during extracorporeal membrane oxygenation: a narrative review

KK Ki, JE Millar, D Langguth, MR Passmore… - Frontiers in …, 2021 - frontiersin.org
A plethora of leukocyte modulations have been reported in critically ill patients. Critical
illnesses such as acute respiratory distress syndrome and cardiogenic shock, which potentially …